Physician profile
Seong Lee
NPI 1669466769
$4,067.40
in general payments reported to CMS, 2019-2025
22 companies · $777 in 2025
The $777 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2020: $1,469 · 2021: $164 · 2022: $246 · 2023: $188 · 2024: $770 · 2025: $777.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,735.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Tcrc, INC. | $1,422.87 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $562.02 | 2019-2025 | Eylea Hd, Eylea |
| Abbvie INC. | $407.67 | 2019-2025 | |
| Sandoz INC. | $318.22 | 2024-2025 | Cimerli |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $265.22 | 2019-2021 | |
| Genentech USA, INC. | $196.06 | 2022-2025 | Vabysmo |
| Coherus Oncology, INC. | $195.68 | 2023-2024 | |
| Astellas Pharma US INC | $188.38 | 2023-2025 | Izervay |
| Novartis Pharmaceuticals Corporation | $121.75 | 2019 | |
| Harrow Eye, LLC | $81.07 | 2024-2025 | Iheezo, Triesence |
| Allergan, INC. | $73.23 | 2021 | |
| Alcon Vision LLC | $68.65 | 2019 | |
| Ani Pharmaceuticals, INC. | $54.68 | 2024-2025 | Purified Cortrophin Gel, Iluvien |
| Horizon Therapeutics Plc | $43.18 | 2021-2023 | Tepezza |
| Eyepoint US, INC. | $35.24 | 2019-2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $33.48 | 2022 |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seong Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.